Security key
36254L308
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,080,160
- Total 13F value
- $38,124,773
- Share change
- +1,004,718
- SEC-reported price per share
- $2.83
- Number of holders
- 16
- Value change
- +$37,905,403
- Number of buys
- 5
- Number of sells
- 6
- Shares outstanding
- 3,148,458
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
16
Top holders
10
GTBP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
GT Biopharma, Inc. SEC filings
GT Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36254L308
Recent filing periods:
Ownership snapshot
Top reported holders of GTBP - GT Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BANK OF MONTREAL /CAN/
Disclosed value leader
BANK OF MONTREAL /CAN/
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $102,142
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BANK OF MONTREAL /CAN/ has the largest disclosed position value at $102.1K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF MONTREAL /CAN/'s linked filing trail.
Disclosed position value
Top 5
BANK OF MONTREAL /CAN/
$102.1K
Manu Ohri
$100.4K
VANGUARD GROUP INC
$90.9K
GEODE CAPITAL MANAGEMENT, LLC
$49.8K
BlackRock Finance, Inc.
$44.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
denominator unverified
|
$102,142
19,872 shares
|
— | 31 Mar 2024 |
| Manu Ohri |
3/4/5
CFO & Secretary
|
—
denominator unverified
|
$100,450
350,000 shares
|
— | 11 Aug 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$90,868
20,512 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$49,787
11,184 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$44,885
10,132 shares
|
— | 31 Mar 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$44,407
10,024 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
1,080,160
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q2 2026 Across Filers
Q2 2026 holders
57
Q2 2024 holders
16
Holder diff
-41
| Investor | Q2 2026 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend